nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—Cytochrome P450 3A Inhibitors—Saquinavir—acquired immunodeficiency syndrome	0.208	0.288	CiPCiCtD
Ranolazine—Cytochrome P450 3A Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.158	0.218	CiPCiCtD
Ranolazine—Cytochrome P450 2D6 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.104	0.144	CiPCiCtD
Ranolazine—P-Glycoprotein Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.0985	0.136	CiPCiCtD
Ranolazine—Cytochrome P450 3A Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0955	0.132	CiPCiCtD
Ranolazine—P-Glycoprotein Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0597	0.0825	CiPCiCtD
Ranolazine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0164	0.0809	CbGbCtD
Ranolazine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0154	0.0761	CbGbCtD
Ranolazine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0154	0.0761	CbGbCtD
Ranolazine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.014	0.0688	CbGbCtD
Ranolazine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.014	0.0688	CbGbCtD
Ranolazine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.012	0.0594	CbGbCtD
Ranolazine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0117	0.0577	CbGbCtD
Ranolazine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0106	0.0521	CbGbCtD
Ranolazine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0106	0.0521	CbGbCtD
Ranolazine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0104	0.0515	CbGbCtD
Ranolazine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00981	0.0484	CbGbCtD
Ranolazine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00981	0.0484	CbGbCtD
Ranolazine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00887	0.0438	CbGbCtD
Ranolazine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00887	0.0438	CbGbCtD
Ranolazine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00766	0.0378	CbGbCtD
Ranolazine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00744	0.0367	CbGbCtD
Ranolazine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00673	0.0332	CbGbCtD
Ranolazine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00673	0.0332	CbGbCtD
Ranolazine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00645	0.0318	CbGbCtD
Ranolazine—SCN9A—spinal cord—acquired immunodeficiency syndrome	0.000155	0.095	CbGeAlD
Ranolazine—SCN9A—lung—acquired immunodeficiency syndrome	0.000141	0.0864	CbGeAlD
Ranolazine—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000117	0.0716	CbGeAlD
Ranolazine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000116	0.0709	CbGeAlD
Ranolazine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000114	0.0698	CbGeAlD
Ranolazine—SCN5A—blood—acquired immunodeficiency syndrome	0.000111	0.0682	CbGeAlD
Ranolazine—SCN5A—vagina—acquired immunodeficiency syndrome	0.000103	0.0632	CbGeAlD
Ranolazine—SCN9A—brain—acquired immunodeficiency syndrome	9.97e-05	0.0612	CbGeAlD
Ranolazine—SCN9A—lymph node—acquired immunodeficiency syndrome	9.63e-05	0.0591	CbGeAlD
Ranolazine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	9.16e-05	0.00126	CcSEcCtD
Ranolazine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.00125	CcSEcCtD
Ranolazine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	9.09e-05	0.00125	CcSEcCtD
Ranolazine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	9.04e-05	0.00124	CcSEcCtD
Ranolazine—SCN5A—nervous system—acquired immunodeficiency syndrome	9.02e-05	0.0554	CbGeAlD
Ranolazine—Shock—Efavirenz—acquired immunodeficiency syndrome	8.99e-05	0.00124	CcSEcCtD
Ranolazine—Nausea—Amprenavir—acquired immunodeficiency syndrome	8.98e-05	0.00124	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	8.98e-05	0.00124	CcSEcCtD
Ranolazine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	8.97e-05	0.00123	CcSEcCtD
Ranolazine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.00123	CcSEcCtD
Ranolazine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	8.97e-05	0.00123	CcSEcCtD
Ranolazine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	8.95e-05	0.00123	CcSEcCtD
Ranolazine—Tremor—Saquinavir—acquired immunodeficiency syndrome	8.94e-05	0.00123	CcSEcCtD
Ranolazine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	8.92e-05	0.00123	CcSEcCtD
Ranolazine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	8.91e-05	0.00122	CcSEcCtD
Ranolazine—Constipation—Zidovudine—acquired immunodeficiency syndrome	8.9e-05	0.00122	CcSEcCtD
Ranolazine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	8.9e-05	0.00122	CcSEcCtD
Ranolazine—Syncope—Ritonavir—acquired immunodeficiency syndrome	8.89e-05	0.00122	CcSEcCtD
Ranolazine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	8.88e-05	0.00122	CcSEcCtD
Ranolazine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	8.87e-05	0.00122	CcSEcCtD
Ranolazine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	8.84e-05	0.00122	CcSEcCtD
Ranolazine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	8.82e-05	0.00121	CcSEcCtD
Ranolazine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	8.77e-05	0.00121	CcSEcCtD
Ranolazine—Vomiting—Didanosine—acquired immunodeficiency syndrome	8.77e-05	0.00121	CcSEcCtD
Ranolazine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	8.76e-05	0.0012	CcSEcCtD
Ranolazine—Insomnia—Indinavir—acquired immunodeficiency syndrome	8.75e-05	0.0012	CcSEcCtD
Ranolazine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	8.75e-05	0.0012	CcSEcCtD
Ranolazine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	8.71e-05	0.0012	CcSEcCtD
Ranolazine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	8.71e-05	0.0012	CcSEcCtD
Ranolazine—Rash—Didanosine—acquired immunodeficiency syndrome	8.69e-05	0.0012	CcSEcCtD
Ranolazine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	8.69e-05	0.0012	CcSEcCtD
Ranolazine—SCN5A—central nervous system—acquired immunodeficiency syndrome	8.69e-05	0.0533	CbGeAlD
Ranolazine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	8.69e-05	0.00119	CcSEcCtD
Ranolazine—Cough—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.00119	CcSEcCtD
Ranolazine—Headache—Didanosine—acquired immunodeficiency syndrome	8.64e-05	0.00119	CcSEcCtD
Ranolazine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	8.63e-05	0.00119	CcSEcCtD
Ranolazine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	8.62e-05	0.00119	CcSEcCtD
Ranolazine—Shock—Delavirdine—acquired immunodeficiency syndrome	8.61e-05	0.00118	CcSEcCtD
Ranolazine—Somnolence—Indinavir—acquired immunodeficiency syndrome	8.6e-05	0.00118	CcSEcCtD
Ranolazine—Asthenia—Stavudine—acquired immunodeficiency syndrome	8.59e-05	0.00118	CcSEcCtD
Ranolazine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	8.57e-05	0.00118	CcSEcCtD
Ranolazine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	8.57e-05	0.00118	CcSEcCtD
Ranolazine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	8.56e-05	0.00118	CcSEcCtD
Ranolazine—Syncope—Saquinavir—acquired immunodeficiency syndrome	8.56e-05	0.00118	CcSEcCtD
Ranolazine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	8.54e-05	0.00117	CcSEcCtD
Ranolazine—Tremor—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.00117	CcSEcCtD
Ranolazine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.00117	CcSEcCtD
Ranolazine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	8.51e-05	0.00117	CcSEcCtD
Ranolazine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	8.5e-05	0.00117	CcSEcCtD
Ranolazine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	8.5e-05	0.00117	CcSEcCtD
Ranolazine—Pruritus—Stavudine—acquired immunodeficiency syndrome	8.47e-05	0.00117	CcSEcCtD
Ranolazine—Asthenia—Abacavir—acquired immunodeficiency syndrome	8.46e-05	0.00116	CcSEcCtD
Ranolazine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	8.46e-05	0.00116	CcSEcCtD
Ranolazine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	8.41e-05	0.00116	CcSEcCtD
Ranolazine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	8.41e-05	0.00116	CcSEcCtD
Ranolazine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	8.38e-05	0.00115	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	8.38e-05	0.00115	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	8.35e-05	0.00115	CcSEcCtD
Ranolazine—Pruritus—Abacavir—acquired immunodeficiency syndrome	8.34e-05	0.00115	CcSEcCtD
Ranolazine—Fatigue—Indinavir—acquired immunodeficiency syndrome	8.34e-05	0.00115	CcSEcCtD
Ranolazine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	8.34e-05	0.00115	CcSEcCtD
Ranolazine—Cough—Saquinavir—acquired immunodeficiency syndrome	8.32e-05	0.00115	CcSEcCtD
Ranolazine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	8.32e-05	0.00114	CcSEcCtD
Ranolazine—Constipation—Indinavir—acquired immunodeficiency syndrome	8.27e-05	0.00114	CcSEcCtD
Ranolazine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	8.27e-05	0.00114	CcSEcCtD
Ranolazine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	8.27e-05	0.00114	CcSEcCtD
Ranolazine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	8.25e-05	0.00114	CcSEcCtD
Ranolazine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	8.23e-05	0.00113	CcSEcCtD
Ranolazine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	8.21e-05	0.00113	CcSEcCtD
Ranolazine—Nausea—Didanosine—acquired immunodeficiency syndrome	8.19e-05	0.00113	CcSEcCtD
Ranolazine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	8.18e-05	0.00112	CcSEcCtD
Ranolazine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	8.17e-05	0.00112	CcSEcCtD
Ranolazine—Syncope—Lamivudine—acquired immunodeficiency syndrome	8.16e-05	0.00112	CcSEcCtD
Ranolazine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	8.16e-05	0.00112	CcSEcCtD
Ranolazine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	8.15e-05	0.00112	CcSEcCtD
Ranolazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	8.15e-05	0.00112	CcSEcCtD
Ranolazine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	8.13e-05	0.00112	CcSEcCtD
Ranolazine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	8.09e-05	0.00111	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	8.07e-05	0.00111	CcSEcCtD
Ranolazine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.00111	CcSEcCtD
Ranolazine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	8e-05	0.0011	CcSEcCtD
Ranolazine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.97e-05	0.0011	CcSEcCtD
Ranolazine—Shock—Ritonavir—acquired immunodeficiency syndrome	7.96e-05	0.00109	CcSEcCtD
Ranolazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.95e-05	0.00109	CcSEcCtD
Ranolazine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	7.94e-05	0.00109	CcSEcCtD
Ranolazine—Cough—Lamivudine—acquired immunodeficiency syndrome	7.94e-05	0.00109	CcSEcCtD
Ranolazine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.94e-05	0.00109	CcSEcCtD
Ranolazine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.00109	CcSEcCtD
Ranolazine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.92e-05	0.00109	CcSEcCtD
Ranolazine—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.92e-05	0.00109	CcSEcCtD
Ranolazine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.91e-05	0.00109	CcSEcCtD
Ranolazine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.91e-05	0.00109	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.89e-05	0.00109	CcSEcCtD
Ranolazine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.88e-05	0.00108	CcSEcCtD
Ranolazine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.88e-05	0.00108	CcSEcCtD
Ranolazine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.86e-05	0.00108	CcSEcCtD
Ranolazine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.85e-05	0.00108	CcSEcCtD
Ranolazine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.85e-05	0.00108	CcSEcCtD
Ranolazine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.82e-05	0.00108	CcSEcCtD
Ranolazine—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.82e-05	0.00108	CcSEcCtD
Ranolazine—Rash—Nevirapine—acquired immunodeficiency syndrome	7.82e-05	0.00108	CcSEcCtD
Ranolazine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.81e-05	0.00107	CcSEcCtD
Ranolazine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.8e-05	0.00107	CcSEcCtD
Ranolazine—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.8e-05	0.00107	CcSEcCtD
Ranolazine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.78e-05	0.00107	CcSEcCtD
Ranolazine—Headache—Nevirapine—acquired immunodeficiency syndrome	7.77e-05	0.00107	CcSEcCtD
Ranolazine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.72e-05	0.00106	CcSEcCtD
Ranolazine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.71e-05	0.00106	CcSEcCtD
Ranolazine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.7e-05	0.00106	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.69e-05	0.00106	CcSEcCtD
Ranolazine—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.69e-05	0.00106	CcSEcCtD
Ranolazine—Shock—Saquinavir—acquired immunodeficiency syndrome	7.66e-05	0.00105	CcSEcCtD
Ranolazine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.65e-05	0.00105	CcSEcCtD
Ranolazine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.64e-05	0.00105	CcSEcCtD
Ranolazine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.63e-05	0.00105	CcSEcCtD
Ranolazine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.00105	CcSEcCtD
Ranolazine—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.61e-05	0.00105	CcSEcCtD
Ranolazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.6e-05	0.00105	CcSEcCtD
Ranolazine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	7.58e-05	0.00104	CcSEcCtD
Ranolazine—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.57e-05	0.00104	CcSEcCtD
Ranolazine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.56e-05	0.00104	CcSEcCtD
Ranolazine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.56e-05	0.00104	CcSEcCtD
Ranolazine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	7.56e-05	0.00104	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.55e-05	0.00104	CcSEcCtD
Ranolazine—Rash—Stavudine—acquired immunodeficiency syndrome	7.55e-05	0.00104	CcSEcCtD
Ranolazine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.54e-05	0.00104	CcSEcCtD
Ranolazine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.54e-05	0.00104	CcSEcCtD
Ranolazine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.53e-05	0.00104	CcSEcCtD
Ranolazine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.00104	CcSEcCtD
Ranolazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.52e-05	0.00103	CcSEcCtD
Ranolazine—Headache—Stavudine—acquired immunodeficiency syndrome	7.5e-05	0.00103	CcSEcCtD
Ranolazine—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.5e-05	0.00103	CcSEcCtD
Ranolazine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.49e-05	0.00103	CcSEcCtD
Ranolazine—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.48e-05	0.00103	CcSEcCtD
Ranolazine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.48e-05	0.00103	CcSEcCtD
Ranolazine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.47e-05	0.00103	CcSEcCtD
Ranolazine—Rash—Abacavir—acquired immunodeficiency syndrome	7.44e-05	0.00102	CcSEcCtD
Ranolazine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.43e-05	0.00102	CcSEcCtD
Ranolazine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	7.42e-05	0.00102	CcSEcCtD
Ranolazine—Headache—Abacavir—acquired immunodeficiency syndrome	7.39e-05	0.00102	CcSEcCtD
Ranolazine—Nausea—Nevirapine—acquired immunodeficiency syndrome	7.36e-05	0.00101	CcSEcCtD
Ranolazine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	7.36e-05	0.00101	CcSEcCtD
Ranolazine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.00101	CcSEcCtD
Ranolazine—Shock—Lamivudine—acquired immunodeficiency syndrome	7.31e-05	0.00101	CcSEcCtD
Ranolazine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.001	CcSEcCtD
Ranolazine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	7.28e-05	0.001	CcSEcCtD
Ranolazine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.001	CcSEcCtD
Ranolazine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.000999	CcSEcCtD
Ranolazine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	7.26e-05	0.000999	CcSEcCtD
Ranolazine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	7.23e-05	0.000994	CcSEcCtD
Ranolazine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	7.21e-05	0.000992	CcSEcCtD
Ranolazine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	7.21e-05	0.000992	CcSEcCtD
Ranolazine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	7.21e-05	0.000992	CcSEcCtD
Ranolazine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	7.19e-05	0.000989	CcSEcCtD
Ranolazine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000988	CcSEcCtD
Ranolazine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	7.15e-05	0.000984	CcSEcCtD
Ranolazine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	7.13e-05	0.000981	CcSEcCtD
Ranolazine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.00098	CcSEcCtD
Ranolazine—Nausea—Stavudine—acquired immunodeficiency syndrome	7.11e-05	0.000978	CcSEcCtD
Ranolazine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	7.08e-05	0.000974	CcSEcCtD
Ranolazine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000969	CcSEcCtD
Ranolazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	7.03e-05	0.000967	CcSEcCtD
Ranolazine—Nausea—Abacavir—acquired immunodeficiency syndrome	7e-05	0.000964	CcSEcCtD
Ranolazine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.99e-05	0.000962	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.98e-05	0.000961	CcSEcCtD
Ranolazine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.97e-05	0.000959	CcSEcCtD
Ranolazine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.95e-05	0.000956	CcSEcCtD
Ranolazine—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.94e-05	0.000955	CcSEcCtD
Ranolazine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.94e-05	0.000955	CcSEcCtD
Ranolazine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.94e-05	0.000955	CcSEcCtD
Ranolazine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.92e-05	0.000952	CcSEcCtD
Ranolazine—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.92e-05	0.000952	CcSEcCtD
Ranolazine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.92e-05	0.000951	CcSEcCtD
Ranolazine—SCN5A—brain—acquired immunodeficiency syndrome	6.9e-05	0.0423	CbGeAlD
Ranolazine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.88e-05	0.000946	CcSEcCtD
Ranolazine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.000943	CcSEcCtD
Ranolazine—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.85e-05	0.000942	CcSEcCtD
Ranolazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.77e-05	0.000931	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.72e-05	0.000925	CcSEcCtD
Ranolazine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000924	CcSEcCtD
Ranolazine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.71e-05	0.000923	CcSEcCtD
Ranolazine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000917	CcSEcCtD
Ranolazine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.67e-05	0.000917	CcSEcCtD
Ranolazine—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.66e-05	0.000916	CcSEcCtD
Ranolazine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.000911	CcSEcCtD
Ranolazine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.62e-05	0.00091	CcSEcCtD
Ranolazine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.61e-05	0.00091	CcSEcCtD
Ranolazine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.6e-05	0.000908	CcSEcCtD
Ranolazine—Rash—Zidovudine—acquired immunodeficiency syndrome	6.56e-05	0.000902	CcSEcCtD
Ranolazine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.56e-05	0.000902	CcSEcCtD
Ranolazine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.55e-05	0.000902	CcSEcCtD
Ranolazine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000899	CcSEcCtD
Ranolazine—Headache—Zidovudine—acquired immunodeficiency syndrome	6.52e-05	0.000897	CcSEcCtD
Ranolazine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.47e-05	0.00089	CcSEcCtD
Ranolazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.46e-05	0.000888	CcSEcCtD
Ranolazine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.000884	CcSEcCtD
Ranolazine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.42e-05	0.000883	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.41e-05	0.000882	CcSEcCtD
Ranolazine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.4e-05	0.000881	CcSEcCtD
Ranolazine—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.4e-05	0.00088	CcSEcCtD
Ranolazine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6.39e-05	0.00088	CcSEcCtD
Ranolazine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.000876	CcSEcCtD
Ranolazine—Constipation—Lamivudine—acquired immunodeficiency syndrome	6.35e-05	0.000874	CcSEcCtD
Ranolazine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.28e-05	0.000863	CcSEcCtD
Ranolazine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.19e-05	0.000851	CcSEcCtD
Ranolazine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000851	CcSEcCtD
Ranolazine—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.18e-05	0.00085	CcSEcCtD
Ranolazine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	6.15e-05	0.000847	CcSEcCtD
Ranolazine—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.15e-05	0.000846	CcSEcCtD
Ranolazine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000842	CcSEcCtD
Ranolazine—Rash—Indinavir—acquired immunodeficiency syndrome	6.1e-05	0.000839	CcSEcCtD
Ranolazine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.1e-05	0.000839	CcSEcCtD
Ranolazine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	6.07e-05	0.000835	CcSEcCtD
Ranolazine—Headache—Indinavir—acquired immunodeficiency syndrome	6.06e-05	0.000834	CcSEcCtD
Ranolazine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	6.05e-05	0.000832	CcSEcCtD
Ranolazine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000812	CcSEcCtD
Ranolazine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000808	CcSEcCtD
Ranolazine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.81e-05	0.0008	CcSEcCtD
Ranolazine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.8e-05	0.000798	CcSEcCtD
Ranolazine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.78e-05	0.000796	CcSEcCtD
Ranolazine—Rash—Efavirenz—acquired immunodeficiency syndrome	5.76e-05	0.000793	CcSEcCtD
Ranolazine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.76e-05	0.000792	CcSEcCtD
Ranolazine—Nausea—Indinavir—acquired immunodeficiency syndrome	5.75e-05	0.000791	CcSEcCtD
Ranolazine—Headache—Efavirenz—acquired immunodeficiency syndrome	5.73e-05	0.000788	CcSEcCtD
Ranolazine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000787	CcSEcCtD
Ranolazine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.59e-05	0.000768	CcSEcCtD
Ranolazine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.56e-05	0.000765	CcSEcCtD
Ranolazine—Rash—Delavirdine—acquired immunodeficiency syndrome	5.52e-05	0.000759	CcSEcCtD
Ranolazine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.51e-05	0.000758	CcSEcCtD
Ranolazine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.51e-05	0.000758	CcSEcCtD
Ranolazine—Headache—Delavirdine—acquired immunodeficiency syndrome	5.48e-05	0.000754	CcSEcCtD
Ranolazine—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.43e-05	0.000747	CcSEcCtD
Ranolazine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.35e-05	0.000736	CcSEcCtD
Ranolazine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.33e-05	0.000733	CcSEcCtD
Ranolazine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.26e-05	0.000723	CcSEcCtD
Ranolazine—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000715	CcSEcCtD
Ranolazine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.15e-05	0.000708	CcSEcCtD
Ranolazine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.14e-05	0.000708	CcSEcCtD
Ranolazine—Rash—Ritonavir—acquired immunodeficiency syndrome	5.1e-05	0.000702	CcSEcCtD
Ranolazine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.1e-05	0.000701	CcSEcCtD
Ranolazine—Headache—Ritonavir—acquired immunodeficiency syndrome	5.07e-05	0.000697	CcSEcCtD
Ranolazine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.95e-05	0.000681	CcSEcCtD
Ranolazine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.91e-05	0.000676	CcSEcCtD
Ranolazine—Rash—Saquinavir—acquired immunodeficiency syndrome	4.91e-05	0.000675	CcSEcCtD
Ranolazine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.9e-05	0.000675	CcSEcCtD
Ranolazine—Headache—Saquinavir—acquired immunodeficiency syndrome	4.88e-05	0.000671	CcSEcCtD
Ranolazine—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.8e-05	0.000661	CcSEcCtD
Ranolazine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.00065	CcSEcCtD
Ranolazine—Rash—Lamivudine—acquired immunodeficiency syndrome	4.68e-05	0.000644	CcSEcCtD
Ranolazine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.68e-05	0.000644	CcSEcCtD
Ranolazine—Headache—Lamivudine—acquired immunodeficiency syndrome	4.65e-05	0.00064	CcSEcCtD
Ranolazine—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.62e-05	0.000636	CcSEcCtD
Ranolazine—CYP3A4—digestive system—acquired immunodeficiency syndrome	4.45e-05	0.0273	CbGeAlD
Ranolazine—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000607	CcSEcCtD
Ranolazine—CYP2D6—digestive system—acquired immunodeficiency syndrome	4.38e-05	0.0268	CbGeAlD
Ranolazine—CYP3A4—blood—acquired immunodeficiency syndrome	4.24e-05	0.026	CbGeAlD
Ranolazine—CYP2D6—blood—acquired immunodeficiency syndrome	4.17e-05	0.0256	CbGeAlD
Ranolazine—CYP3A4—nervous system—acquired immunodeficiency syndrome	3.44e-05	0.0211	CbGeAlD
Ranolazine—CYP2D6—nervous system—acquired immunodeficiency syndrome	3.38e-05	0.0208	CbGeAlD
Ranolazine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	3.31e-05	0.0203	CbGeAlD
Ranolazine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	3.26e-05	0.02	CbGeAlD
Ranolazine—CYP2D6—brain—acquired immunodeficiency syndrome	2.59e-05	0.0159	CbGeAlD
